Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell. 2010 Aug 20; 142(4):531-43.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.